49 Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

49 Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-418	Closed	-$205K	–	284
2026 Q1	$205K	Buy	+418	New	+$227K	0.02%	187
2024 Q4	–	Sell	-425	Closed	-$263K	–	191
2024 Q3	$263K	Sell	425 -5	-1%	-$2.96K	0.04%	132
2024 Q2	$233K	Buy	+430	New	+$246K	0.05%	132

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

49 Wealth Management's TMO Position: Q2 2026 in Review

49 Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 418 shares — an estimated $205K sold.

49 Wealth Management first reported a position in TMO in Q2 2024 and held it in 3 quarters. The position peaked at $263K in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

49 Wealth Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
49 Wealth Management sold 418 Thermo Fisher Scientific shares in Q2 2026, an estimated $205K.
49 Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2024 and held it in 3 quarters.
49 Wealth Management's Thermo Fisher Scientific position peaked at $263K in Q3 2024.
2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on 49 Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.